Form 4: Ronda E. Stryker Receives RSU Grant from Stryker Corp

Director Ronda E. Stryker was granted 762 restricted stock units as part of standard equity compensation.

Summary

• Director Ronda E. Stryker acquired 762 restricted stock units (RSUs) on May 6, 2026.
• Each RSU represents a contingent right to receive one share of Stryker common stock.
• The RSUs are scheduled to vest 100% on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027.
• Following this transaction, the reporting person holds 1,322 shares directly and maintains significant indirect holdings through various trusts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no impact on company operations or financial outlook.

Positives

• The transaction reflects standard equity-based compensation for a director, aligning interests with shareholders.

Negatives

• None.

Risks

• None.

Future Outlook

The RSUs will vest in May 2027, subject to the director's continued service.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices in the medical technology sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with compensation practices at large-cap medical device companies like Medtronic and Boston Scientific.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity grant.

Next Steps

• Vesting of RSUs on May 6, 2027.

Key Dates

Keywords

Stryker, SYK, Insider Trading, Form 4, Director Compensation, Restricted Stock Units